Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Pfizer present new oral PDE5 inhibitor as a candidate for male erectile dysfunction

May 31, 2006

Recent Kotobuki patent describes new agents for hyperphosphatemia

May 25, 2006

Prous Science webcasts AUA Annual Meeting in Atlanta

May 24, 2006

Study supports once-daily dosing of SLx-2101

May 23, 2006

Avanafil effective in men with mild to moderate erectile dysfunction

May 23, 2006

IP-751 demonstrates efficacy against bladder irritation in vivo

May 22, 2006

DDP-225 improves bladder irritation and capacity in animal models

May 22, 2006

Activity of BXL-628 indicative of efficacy in overactive bladder

May 22, 2006

More positive data reported for Nymox's BPH drug candidate

May 19, 2006

Effect of sildenafil on peak systolic velocity a mechanism of erection improvement

May 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...